MENU
+Compare
XENE
Stock ticker: NASDAQ
AS OF
Apr 3, 04:59 PM (EDT)
Price
$30.68
Change
-$0.78 (-2.48%)
Capitalization
2.41B

XENE Xenon Pharmaceuticals Forecast, Technical & Fundamental Analysis

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders... Show more

Industry: #Biotechnology
XENE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for XENE with price predictions
Apr 02, 2025

XENE's RSI Oscillator sits in oversold zone for 1 day

It is expected that a price bounce should occur soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XENE advanced for three days, in of 294 cases, the price rose further within the following month. The odds of a continued upward trend are .

XENE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 26, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on XENE as a result. In of 111 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for XENE turned negative on March 31, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 57 similar instances when the indicator turned negative. In of the 57 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XENE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for XENE entered a downward trend on April 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. XENE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.190) is normal, around the industry mean (13.260). P/E Ratio (0.000) is within average values for comparable stocks, (64.931). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.878). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.036).

View a ticker or compare two or three
XENE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

XENE is expected to report earnings to rise 9.70% to -92 cents per share on May 13

Xenon Pharmaceuticals XENE Stock Earnings Reports
Q1'25
Est.
$-0.92
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.01
Q2'24
Missed
by $0.05
Q1'24
Beat
by $0.04
The last earnings report on February 27 showed earnings per share of -83 cents, beating the estimate of -85 cents. With 448.25K shares outstanding, the current market capitalization sits at 2.41B.
A.I. Advisor
published General Information

General Information

a provider of drug discovery and development services

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
200-3650 Gilmore Way
Phone
+1 604 484-3300
Employees
259
Web
https://www.xenon-pharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RSLDX64.680.83
+1.30%
American Funds SMALLCAP World R5E
FDEGX61.79N/A
N/A
Fidelity Growth Strategies
HOVLX51.70N/A
N/A
Homestead Value
EQIRX12.02N/A
N/A
Allspring Emerging Markets Eq Advtg R6
LDMIX13.60-0.02
-0.15%
Lazard Developing Markets Equity Instl

XENE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, XENE has been loosely correlated with KYMR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if XENE jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XENE
1D Price
Change %
XENE100%
+2.68%
KYMR - XENE
46%
Loosely correlated
+4.46%
IDYA - XENE
46%
Loosely correlated
+10.70%
RGNX - XENE
45%
Loosely correlated
+4.29%
CRNX - XENE
44%
Loosely correlated
+2.51%
MLTX - XENE
44%
Loosely correlated
+4.68%
More